Sign Out
No teratogenic effects have been observed in patients or in animals. However, caution is recommended during the first trimester of pregnancy.
Maintenance treatment with oral beta2-agonists for asthma and other pulmonary diseases should be used with caution at the end of pregnancy because of the potential tocolytic effect.
Terbutaline passes over to breast milk but an influence on the child is unlikely with therapeutic doses.
Transient hypoglycemia has been reported in newborn preterm infants after maternal β2-agonist treatment.
Continue with Google